Watanabe Todd

See Remarks | President And CEO

1 company

Strong

Trades Analyzed

12M Win Rate

69.8%

Avg 3M Return

+4.5%

Avg 12M Return

+14.0%

Watanabe Todd is a See Remarks at Arcutis Biotherapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 17 sells.

Estimated insider holdings value: $19.4M based on current market prices.

Holdings by Company

ARQTNov 24, 2025

Current Shares740.5K

Value$19.41M

Net Activity-376,935

Bought: 7.5KSold: 384.4K

Showing 10 filings

Date	Ticker	Role	Type	Shares	Price	Value	Chg%	3M	12M
Nov 24, 2025	ARQT Arcutis Biotherapeutics, Inc.	See Remarks	Sell	50,000	$30.35	$1,517,404.84	-3.2%	-14.5%	-
Nov 3, 2025	ARQT Arcutis Biotherapeutics, Inc.	See Remarks	Sell	11,547	$24.72	$285,399.17	-0.7%	+3.3%	-
Oct 28, 2025	ARQT Arcutis Biotherapeutics, Inc.	See Remarks	Sell	40,000	$25.03	$1,001,032.00	-4.7%	+5.5%	-
Oct 2, 2025	ARQT Arcutis Biotherapeutics, Inc.	See Remarks	Sell	45,000	$19.66	$884,648.68	-1.7%	+36.7%	-
Sep 9, 2025	ARQT Arcutis Biotherapeutics, Inc.	See Remarks	Sell	10,129	$17.54	$177,628.42	-0.6%	+73.1%	-
Aug 4, 2025	ARQT Arcutis Biotherapeutics, Inc.	See Remarks	Sell	11,547	$14.33	$165,429.25	-1.3%	+70.5%	-
May 2, 2025	ARQT Arcutis Biotherapeutics, Inc.	See Remarks	Sell	11,448	$15.19	$173,916.87	-1.2%	-4.3%	+53.2%
Mar 25, 2025	ARQT Arcutis Biotherapeutics, Inc.	See Remarks	Sell	3,671	$17.55	$64,413.39	-0.2%	-15.8%	+32.9%
Mar 17, 2025	ARQT Arcutis Biotherapeutics, Inc.	See Remarks	Sell	1,200	$17.61	$21,137.04	-0.1%	-18.4%	+38.4%
Mar 4, 2025	ARQT Arcutis Biotherapeutics, Inc.	See Remarks	Sell	25,015	$13.07	$327,019.12	-1.3%	+0.6%	+80.1%